This post was originally published on this site
ARUN GUPTA
EXECUTIVE CHAIRMAN
BIG HEALTH
WHY: Head of app maker focused on developing non-drug options for common mental health conditions. Joined the company’s board in 2019 before being named CEO in 2022. Runs the San Francisco-based company out of Newport Beach, overseeing 200 employees. Has a long track record of running startups and also founded Quartet Health, where he raised hundreds of millions in capital by providing insurers and health systems with a way to enhance collaboration between physical and mental health providers.
IN THE NEWS: The company’s two digital therapeutics SleepioRx, intended to treat insomnia, and DaylightRx for generalized anxiety disorders, received FDA approval last year, making it so doctors can prescribe them as treatments to patients. Both clinical trials, which had more than 300 participants each, reported an average remission rate of above 70% by the 12-to-16-week mark. Offers six total digital therapeutics, including SparkRx, a new offering from Big Health’s acquisition of San Francisco-based Limbix. The app aims to treat teens with symptoms of depression.
NOTABLE: Company has raised approximately $130M to date with plans to raise more in light of receiving FDA clearance. Recognized at the Business Journal’s Innovator of the Year Awards last year.
IN THEIR WORDS: “If we can’t get everybody to a therapist, the next best thing is getting them into a self-paced, evidence-based program that models that therapeutic relationship as best we can.”
